|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.62 USD | -0.57% |
|
-1.25% | +1.17% |
| Capitalization | 112B 95.12B 88.17B 82.39B 154B 10,276B 163B 1,008B 400B 4,852B 419B 411B 17,649B | P/E ratio 2025 * |
14.1x | P/E ratio 2026 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise value | 146B 124B 115B 107B 200B 13,379B 212B 1,312B 521B 6,317B 546B 535B 22,978B | EV / Sales 2025 * |
3.04x | EV / Sales 2026 * | 3.16x |
| Free-Float |
67.93% | Yield 2025 * |
4.48% | Yield 2026 * | 4.6% |
Last Transcript: Bristol-Myers Squibb Company
| 1 day | -0.57% | ||
| 1 week | -1.25% | ||
| Current month | +1.17% | ||
| 1 month | +0.53% | ||
| 3 months | +24.50% | ||
| 6 months | +11.41% | ||
| Current year | +1.17% |
| 1 week | 53.54 |  | 55.52 |
| 1 month | 52.06 | | 57.04 |
| Current year | 52.06 | | 57.04 |
| 1 year | 42.52 | | 63.33 |
| 3 years | 39.35 | | 75.18 |
| 5 years | 39.35 | | 81.44 |
| 10 years | 39.35 | | 81.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2023-10-31 | |
David Elkins
DFI | Director of Finance/CFO | 58 | 2019-11-19 |
| Compliance Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2024-03-31 | |
Peter Arduini
BRD | Director/Board Member | 61 | 2016-03-31 |
Theodore Samuels
BRD | Director/Board Member | 71 | 2017-02-20 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.36% | 12.97% | 253 M€ | |
| +0.75% | 4.01% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.57% | -1.25% | -7.73% | -25.51% | 112B | |
| -1.93% | +2.99% | +39.51% | +212.52% | 974B | |
| +0.96% | +1.10% | +50.75% | +31.34% | 526B | |
| +0.46% | +2.42% | +28.63% | +47.79% | 385B | |
| +0.06% | +0.69% | +27.14% | +18.28% | 376B | |
| +0.15% | -3.18% | +23.01% | +21.25% | 284B | |
| +0.47% | +1.01% | +28.88% | +36.88% | 279B | |
| +1.17% | +9.90% | -30.99% | -16.90% | 277B | |
| -0.81% | -0.59% | +11.96% | -1.54% | 271B | |
| -0.62% | +4.27% | +23.98% | +32.02% | 187B | |
| Average | -0.10% | +1.25% | +19.51% | +35.61% | 367.14B | |
| Weighted average by Cap. | -0.29% | +1.95% | +27.04% | +71.65% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 47.97B 40.8B 37.82B 35.34B 65.88B 4,408B 69.83B 432B 172B 2,081B 180B 176B 7,570B | 44.09B 37.5B 34.76B 32.48B 60.54B 4,051B 64.17B 397B 158B 1,912B 165B 162B 6,957B |
| Net income | 7.65B 6.5B 6.03B 5.63B 10.5B 702B 11.13B 68.88B 27.35B 332B 28.67B 28.08B 1,206B | 8.83B 7.51B 6.96B 6.51B 12.13B 811B 12.85B 79.56B 31.59B 383B 33.11B 32.43B 1,393B |
| Net Debt | 33.77B 28.72B 26.62B 24.88B 46.38B 3,103B 49.16B 304B 121B 1,465B 127B 124B 5,329B | 27.27B 23.2B 21.5B 20.09B 37.46B 2,506B 39.7B 246B 97.56B 1,183B 102B 100B 4,304B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 54.54 $ | -0.73% | 5,668,626 |
| 26-01-22 | 54.94 $ | +0.81% | 12,277,497 |
| 26-01-21 | 54.50 $ | +0.52% | 15,834,800 |
| 26-01-20 | 54.22 $ | -1.88% | 15,349,984 |
| 26-01-16 | 55.26 $ | -2.40% | 13,702,877 |
Delayed Quote Nyse, January 23, 2026 at 03:36 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition